Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Malaria: Opportunity Analysis and Forecasts to 2027” report has been added to ResearchAndMarkets.com’s offering. “Malaria: Opportunity Analysis and…
About a quarter of countries in sub-Saharan Africa receive little funding for research into malaria despite having high death rates, according to a study on Thursday that highlighted the unequal spread of resources to tackle the disease.
A medical diagnostics company focused on allergy, food intolerance and infectious disease, Omega, has CE-Marked its Visitect range of Malaria tests.
A drug widely used to cure malaria has failed for the first time in patients being treated in Britain, raising questions over whether the parasite is becoming resistant to drugs, researchers said on Tuesday
Novartis has reached a delivery milestone of 300 million pediatric antimalarial treatments supplied without profit since 2009, helping to reduce the disease burden for children in more than 30 malaria-endemic countries.
Takeda Pharmaceutical Company Limited will participate in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines,…